Baughman G et al. |
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. |
1995 |
Mol. Cell. Biol. |
pmid:7542743
|
Su Q et al. |
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase. |
1995 May-Jun |
Ren. Physiol. Biochem. |
pmid:7542793
|
Warty V et al. |
Tacrolimus analysis: a comparison of different methods and matrices. |
1995 |
Ther Drug Monit |
pmid:7542809
|
Freeman DJ et al. |
Stability of FK 506 in whole blood samples. |
1995 |
Ther Drug Monit |
pmid:7542810
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Sihra TS et al. |
A role for calcineurin (protein phosphatase-2B) in the regulation of glutamate release. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7542882
|
Dumont FJ et al. |
Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma. |
1995 |
Exp. Cell Res. |
pmid:7543051
|
Corey HE et al. |
Renal allograft rejection in children and young adults: the Banff classification. |
1995 |
Pediatr. Nephrol. |
pmid:7543274
|
Griffith JP et al. |
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. |
1995 |
Cell |
pmid:7543369
|
Prud'homme GJ et al. |
Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy. |
1995 |
Cell. Immunol. |
pmid:7543371
|
Migita K et al. |
FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. |
1995 |
J. Clin. Invest. |
pmid:7543492
|
Lhoëst G et al. |
The in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7543569
|
Textor SC et al. |
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. |
1995 |
Kidney Int. |
pmid:7543625
|
Dollinger MM et al. |
Tacrolimus and cardiotoxicity in adult liver transplant recipients. |
1995 |
Lancet |
pmid:7543645
|
Romero DF et al. |
Rapamycin: a bone sparing immunosuppressant? |
1995 |
J. Bone Miner. Res. |
pmid:7543725
|
Rebollo A et al. |
Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. |
1995 |
Cytokine |
pmid:7543780
|
Lam E et al. |
Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs. |
1995 |
Gene |
pmid:7543869
|
Minamoto A et al. |
Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty. |
1995 |
Jpn. J. Ophthalmol. |
pmid:7543958
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Ishikawa A et al. |
[A case of tacrolimus-induced glucose intolerance following renal allografting]. |
1995 |
Hinyokika Kiyo |
pmid:7544064
|
Lochmüller H et al. |
Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7544122
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Rouvière-Fourmy N et al. |
1H and 15N assignment of NMR spectrum, secondary structure and global folding of the immunophilin-like domain of the 59-kDa FK506-binding protein. |
1995 |
Eur. J. Biochem. |
pmid:7544285
|
Sakamoto K et al. |
A new assay method for immunosuppressants with a tacrolimus (FK506)-like mode of action. |
1995 |
J. Antibiot. |
pmid:7544337
|
Lee MJ et al. |
Combined inhibition effects of tacrolimus and methylprednisolone on in vitro human lymphocyte proliferation. |
1995 |
Immunopharmacol Immunotoxicol |
pmid:7544367
|
Sauer P et al. |
In patients with orthotopic liver transplantation, serum markers of cholestasis are unreliable indicators of biliary secretion. |
1995 |
J. Hepatol. |
pmid:7544368
|
Chang HY et al. |
Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. |
1995 |
Nature |
pmid:7544441
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Llull R et al. |
Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. |
1995 |
Transplant. Proc. |
pmid:7544504
|
Hayashi S et al. |
Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation. |
1995 May-Jun |
J. Heart Lung Transplant. |
pmid:7544621
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Firdaous I et al. |
HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. |
1995 |
Clin. Chem. |
pmid:7544705
|
Ingels SC et al. |
Stability of FK506 (tacrolimus) in whole-blood specimens. |
1995 |
Clin. Chem. |
pmid:7544707
|
Takizawa H et al. |
Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. |
1995 |
Digestion |
pmid:7544748
|
Sher LS and Makowka L |
Immunosuppression: now we have choices. |
1995 |
Hepatology |
pmid:7544759
|
Perrot-Applanat M et al. |
The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. |
1995 |
J. Cell. Sci. |
pmid:7544801
|
Hibi S et al. |
Severe rhabdomyolysis associated with tacrolimus. |
1995 |
Lancet |
pmid:7544861
|
Kinoshita I et al. |
Myoblast allotransplantation in primates. |
1995 |
Muscle Nerve |
pmid:7544871
|
Monsour HP et al. |
Renal insufficiency and hypertension as long-term complications in liver transplantation. |
1995 |
Semin. Liver Dis. |
pmid:7544917
|
Varela E |
[Small bowel transplantation]. |
1995 |
Acta Gastroenterol. Latinoam. |
pmid:7544939
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Robertus J |
Structure-based drug design ten years on. |
1994 |
Nat. Struct. Biol. |
pmid:7545074
|
Teague S |
Lessons from molecular matchmakers. |
1995 |
Nat. Struct. Biol. |
pmid:7545076
|
Ito T et al. |
Immunosuppressive agents induce the reduction of local pancreatic blood flow. |
1995 |
Pancreas |
pmid:7545292
|
Winkler M and Christians U |
A risk-benefit assessment of tacrolimus in transplantation. |
1995 |
Drug Saf |
pmid:7545405
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Hattori Y and Nakanishi N |
Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. |
1995 |
Cell. Immunol. |
pmid:7545550
|
Han JW et al. |
Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. |
1995 |
J. Biol. Chem. |
pmid:7545671
|
Ruff VA and Leach KL |
Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. |
1995 |
J. Biol. Chem. |
pmid:7545680
|
Matsuo S and Okamoto K |
Enhancement of FK-506 activities by ganglioside (GM3) in vivo. |
1995 |
Life Sci. |
pmid:7545772
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Bolman RM |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients. |
1995 |
Ann. Thorac. Surg. |
pmid:7545888
|
Keenan RJ et al. |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. |
1995 |
Ann. Thorac. Surg. |
pmid:7545889
|
Okamoto M et al. |
In situ proliferating status of mononuclear cells in rat small bowel grafts. |
1995 |
Int J Exp Pathol |
pmid:7547442
|
Pham SM et al. |
Cardiac transplantation at the University of Pittsburgh: 1994 update. |
1994 |
Clin Transpl |
pmid:7547531
|
Abu-Elmagd K et al. |
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. |
1994 |
Clin Transpl |
pmid:7547533
|
Shapiro R et al. |
Renal transplantation at the University of Pittsburgh: the impact of FK506. |
1994 |
Clin Transpl |
pmid:7547544
|
Platz KP et al. |
Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation. |
1995 |
Clin Transplant |
pmid:7549052
|
Mueller AR et al. |
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506? |
1995 |
Clin Transplant |
pmid:7549057
|
Nagai H et al. |
Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. |
1995 |
Int. Arch. Allergy Immunol. |
pmid:7549508
|
Reisman L et al. |
Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. |
1995 |
Transpl. Immunol. |
pmid:7551978
|
Woo J et al. |
Effects of FK 506 on chimerism and the induction of donor-specific unresponsiveness following fully allogeneic bone marrow transplantation in mice. |
1995 |
Transpl. Immunol. |
pmid:7551985
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Holmes JA and Twentyman PR |
The activity of deoxyspergualin in multidrug-resistant cells. |
1995 |
Cancer Chemother. Pharmacol. |
pmid:7554042
|
Elitsur Y et al. |
FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system. |
1995 |
Dig. Dis. Sci. |
pmid:7555446
|
Kobayashi I et al. |
Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. |
1995 |
Eur. J. Pediatr. |
pmid:7556338
|
Adachi M et al. |
IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor beta chain. |
1995 |
FEBS Lett. |
pmid:7556630
|
David M et al. |
[Occurrence of suspicious changes in cervix cytology in women after liver transplantation]. |
1995 |
Geburtshilfe Frauenheilkd |
pmid:7557217
|
Zhu D et al. |
Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae. |
1995 |
J. Biol. Chem. |
pmid:7559604
|
|
[Experimental and clinical studies on the effectiveness of new immunosuppressive agents used in heart transplantation and transplantation-related complications]. |
1995 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7561285
|
Dix SP et al. |
Re: Severe interaction between methotrexate and a macrolide-like antibiotic. |
1995 |
J. Natl. Cancer Inst. |
pmid:7563209
|
Hadad SJ et al. |
FK 506: effects on glomerular hemodynamics and on mesangial cells in culture. |
1995 |
Kidney Int. |
pmid:7564092
|
Mazur P et al. |
Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. |
1995 |
Mol. Cell. Biol. |
pmid:7565718
|
Spencer DM et al. |
A general strategy for producing conditional alleles of Src-like tyrosine kinases. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7568222
|
Holsinger LJ et al. |
Signal transduction in T lymphocytes using a conditional allele of Sos. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7568223
|
DÃaz M et al. |
[Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)]. |
1995 Apr-Jun |
Rev Med Univ Navarra |
pmid:7569553
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Petrides AS |
[Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?]. |
1995 |
Z Gastroenterol |
pmid:7571761
|
Thomson AW and Bonham CA |
Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. |
1995 |
Adv. Exp. Med. Biol. |
pmid:7572394
|
Paterson JM et al. |
Control of a novel adenylyl cyclase by calcineurin. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7575502
|
Cunningham EB |
The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7575593
|
Ellis D |
Clinical use of tacrolimus (FK-506) in infants and children with renal transplants. |
1995 |
Pediatr. Nephrol. |
pmid:7577418
|
Furuke K et al. |
Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control. |
1995 |
Int. Immunol. |
pmid:7577807
|
Kawahara K et al. |
Effects of deoxyspergualin on bronchial anastomosis healing in canine pulmonary allografts. |
1995 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7578196
|
Mehta BA et al. |
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. |
1995 |
Blood |
pmid:7579455
|
Hemenway C |
FK506 in bone marrow transplantation. |
1995 |
Blood |
pmid:7579473
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
O'Gorman MA et al. |
Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients. |
1995 |
Clin Transplant |
pmid:7579739
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Koehler MT et al. |
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:7581088
|
Jung-Testas I et al. |
Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant. |
1995 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7583777
|
Kahan BD |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. |
1994 |
Ther Immunol |
pmid:7584478
|
Tsuchida M et al. |
The effects of FK506 and dexamethasone on rat thymocyte differentiation. |
1994 |
Ther Immunol |
pmid:7584489
|
Lauerma AI |
Immunomodulation of contact dermatitis. |
1995 |
Curr. Probl. Dermatol. |
pmid:7587333
|
Wera S et al. |
Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture. |
1995 |
Endocr. Res. |
pmid:7588431
|
Stoller G et al. |
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. |
1995 |
EMBO J. |
pmid:7588623
|
Farcasanu IC et al. |
Protein phosphatase 2B of Saccharomyces cerevisiae is required for tolerance to manganese, in blocking the entry of ions into the cells. |
1995 |
Eur. J. Biochem. |
pmid:7588708
|